市场调查报告书
商品编码
1298657
蛋白质工程市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Protein Engineering Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球蛋白质工程市场规模达到30亿美元。展望未来,IMARC集团预计到2028年,市场规模将达到57亿美元,在2023-2028年期间表现出11.2%的增长率(CAGR)。
蛋白质工程是指开发或改变蛋白质序列以达到预期结果的过程。它涉及到新蛋白质的合成或现有结构或序列的修正,并采用重组脱氧核糖核酸(DNA)技术来改变氨基酸序列以获得新的和增强的功能。它被广泛用于生产大量的酶或蛋白质,以便在工业环境中使用。近年来,研究人员已经成功地设计了一系列适合医药、研究、工业、健康和生物技术应用的蛋白质,这使它们在全球的需求不断增加。
对合成生物学的投资增加,以及对基于蛋白质的药物开发的关注度提高,是推动市场增长的主要因素。此外,由于非蛋白质药物具有积极的临床效果,人们已经开始向蛋白质治疗药物转变。这一点,再加上蛋白质缺乏的疾病的广泛流行,正在增加对蛋白质工程的需求。此外,各国政府采取的一些有利倡议,如增加对蛋白质工程领域的研究和开发(R&D)活动的资助,正在推动市场增长。除此之外,重组单克隆抗体(mAbs)的出现和越来越多地使用单克隆抗体来治疗各种疾病,如癌症和自身免疫性疾病,正在加速产品的采用率。此外,正在进行的在农业化学工业中应用蛋白质工程的研究,以产生具有增强功能的酶来增加作物产量或促进生物燃料的生产,正在催化市场增长。其他因素,包括对个性化药物的需求升级、对生物仿制药和生物制剂的需求增长、医疗保健基础设施的改善、技术进步和产品创新,也在为市场创造积极的前景。
The global protein engineering market size reached US$ 3.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.2% during 2023-2028.
Protein engineering refers to the process of developing or changing a protein sequence to achieve the desired result. It involves the synthesis of new proteins or amendments in the existing structure or sequence and employs recombinant deoxyribonucleic acid (DNA) technology to alter amino acid sequences for novel and enhanced functions. It is widely utilized for the production of enzymes or proteins in large quantities for use in industrial settings. In recent years, researchers have successfully engineered a wide range of proteins tailored to medicine, research, industry, health, and biotechnology applications, which is escalating their demand across the globe.
The rising investments in synthetic biology and the improving focus toward protein-based drug development represent the primary factors driving the market growth. Additionally, there has been a significant shift toward protein therapeutics from non-protein drugs due to their associated positive clinical outcomes. This, in confluence with the widespread prevalence of protein-deficient diseases, is increasing the demand for protein engineering. Furthermore, several favorable initiatives undertaken by the government of various countries, such as increased funding for research and development (R&D) activities in the field of protein engineering, are propelling the market growth. Besides this, the advent of recombinant monoclonal antibodies (mAbs) and the increasing usage of monoclonal antibodies to treat various diseases, such as cancer and autoimmune diseases, are accelerating product adoption rates. Moreover, the ongoing research for applications of protein engineering in the agrochemical industry to generate enzymes with enhanced function to increase the crop yield or facilitate biofuel production is catalyzing the market growth. Other factors, including the escalating demand for personalized medicines, growing need for biosimilars and biologics, improving healthcare infrastructure, technological advancements, and product innovations, are also creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global protein engineering market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product & services, protein type, technology and end user.
Instruments
Reagents
Services and Software
Insulin
Monoclonal Antibodies
Coagulation Factors
Vaccines
Growth Factors
Others
Irrational Protein Design
Rational Protein Design
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Contract Research Organizations
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abzena Ltd., Agilent Technologies Inc., Amgen Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Codexis Inc., Danaher Corporation, Eli Lilly and Company, General Electric Company, Merck KGaA, Novo Nordisk A/S, PerkinElmer Inc., Thermo Fisher Scientific Inc. and Waters Corporation.
Key Questions Answered in This Report
1. What was the size of the global protein engineering market in 2022?
2. What is the expected growth rate of the global protein engineering market during 2023-2028?
3. What are the key factors driving the global protein engineering market?
4. What has been the impact of COVID-19 on the global protein engineering market?
5. What is the breakup of the global protein engineering market based on the product and services?
6. What is the breakup of the global protein engineering market based on the protein type?
7. What is the breakup of the global protein engineering market based on the technology?
8. What is the breakup of the global protein engineering market based on the end user?
9. What are the key regions in the global protein engineering market?
10. Who are the key players/companies in the global protein engineering market?